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Abstract
Treatment planning in High Dose Rate (HDR) brachytherapy based on three‐dimen‐
sional (3D) imaging allows for prearranging and realization optimal treatment process. 
This process consists of procedure planning, the choice of applicators, adjusting the 
appropriate implantation technique, and planning of three‐dimensional distribution of 
dose in computerized treatment planning system. 3D images used in treatment planning 
in HDR brachytherapy allows for choosing the most appropriate application technique. 
This in turn allows for the best area coverage by reference dose with simultaneous pro‐
tection of critical organs. Treatment planning on 3D images assures individual planning 
of dose dispersion in target area. Several techniques will be presented based on 3D imag‐
ing in location such as lung, skin cancer, breast, and prostate cancer. For each location, 
relative cases will be provided where different applicators and techniques were applied. 
These examples are going to present images from before and after performed application 
along with the pictures from computer treatment planning system. In each of described 
locations, relative advice and rules of conducting accurate application will be provided.
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1. Introduction
HDR brachytherapy is a radiotherapy method in which a source of ionizing radiation is 
administered directly into the tumor area or to its nearest surroundings. Dissemination of 
this method, nowadays, is associated with the possibility of using radiation sources with rela‐
tively low dimension. Small size of capsules made administration of catheter possible in the 
areas where previously it would have not been possible or would have involved a number of 
inconveniences for the patient as well as considerable risks of complications, e.g., bronchial 
© 2017 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
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carcinoma. This unique method also provides the possibility to determine the exact location 
of catheter in the tumor area for applying several visualization methods.
The purpose of the following chapter is to introduce practical application of HDR brachy‐
therapy based on the three‐dimensional (3D) computed tomography method. This publica‐
tion is for those who are interested in applying and using 3D images in HDR brachytherapy 
and are searching for practical treatment examples based on this method. The purpose of this 
section is to spread treatment HDR brachytherapy treatment planning based on 3D images. 
The majority of brachytherapy departments still base their treatment on 2D imaging in spite 
of relatively popular CT scanners.
This chapter aims to familiarize the reader with treatment planning based on CT imaging to 
draw attention to the benefits coming from this method not only for the treatment planning 
but also for the patient. It is a practical guide based on brachytherapy department experiences 
located in Subcarpathian Cancer Center.
This chapter includes CT images presenting brachytherapy treatment in different stages of 
treatment planning. It is going to introduce a course of planning process in different locations 
as well as the application methods used in correspondence to the location of the treatment. 
With each location, relevant suggestions and recommendations will be provided, which 
would improve the whole treatment planning process.
This chapter is mainly addressed to radiotherapy specialists but also residents, physical med‐
ics, radiologists, and everyone who is interested in the topic of applying CT imaging in HDR 
brachytherapy.
First section deals with what the approach of brachytherapy is and what imaging methods 
it uses. Also, the differences emerging from using different imaging methods and locations 
where 3D imaging was used will be described as well as the methods applied to enhance 
the treatment planning procedure. It will illustrate the guidelines we use in our department 
when treating different tumor locations along with the necessary equipment relevant in the 
3D imaging method.
Second section will demonstrate, in detail, its applications in various locations. In this  chapter, 
I am going to demonstrate the utilization of HDR brachytherapy in treatment of breast, pros‐
tate, skin, and lung cancers. Depending on the tumor location, one or more examples will 
be provided. For each case, there will be one accepted treatment plan presented. Each case 
includes a wide range of materials in the form of CT images and computed planning system, 
each of them will be described under the angle of planning and conducting in most optimal 
application, based on the experience of our department. I am going to present several plan‐
ning stages, starting from CT scans on different application levels to the demonstration of 
images and results of computer treatment planning system (TPS).
2. Treatment planning in brachytherapy HDR
Brachytherapy HDR is administration of a source of ionizing radiation into the immedi‐
ate vicinity of the tumor. Because of the high gradient dose, the administered application 
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allows for reduction of ionizing radiation in the critical organs area with simultaneous 
coverage of tumor area with reference dose. Treatment planning process can be based 
on two‐ and three‐dimensional imaging. In case of 2D imaging, distribution of dosage 
around the catheter would conventionally be calculated on X‐ray pictures taken in two 
different projections. This reconstruction allows us to determine the dose around the 
guide or guides [1]. We do not have the exact information about the dose in the target and 
the critical organs in the immediate vicinity to catheter. When planning a treatment, CT 
images provide actual information about the location of the applicator, target, and organ 
at risk (OAR). Images from computer tomography are electronic cross‐sections (scans) 
of a patient body, which includes cancerous areas. The distance between those scans is 
adjusted accordingly to achieve best‐possible three‐dimensional reconstruction of the 
patient’s body. It is necessary to calculate and determine the dose on the clear scans from 
the CT. The dosage calculation area here is the patient’s body. Second, radiation area is 
determined along with critical organs and structures. Using the linear method, involving 
manual or automatic contouring of selected areas in each scan, ionizing areas are deter‐
mined as well as critical organs and structures. Ionizing area in brachytherapy is defined 
by a three‐step process:
• Gross tumor volume (GTV)—macroscopic tumor area defined by diagnostic methods.
• Clinical target volume (CTV)—clinical area for radiation.
• Planning target volume (PTV)—1 cm safety margin top‐bottom in regard to CTV and addi‐
tional 1 cm resulting from uncertain location of catheter or possible applicator movements 
caused, i.e., transporting the patient.
As a result of reconstruction, you get a three‐dimensional image of target volume and critical 
organs. Application of computer treatment planning methods enables a precise dosage cal‐
culation. Dosage distribution is determined using formalism TG‐43 or Monte Carlo method. 
Individual treatment plan is verified before the treatment starts. Designated dosage, active 
length, dwell times, and source activity are being confirmed. Once all these data have been 
verified, the treatment plan begins to be realized.
The main purpose of treatment planning based on computed tomography images is to deter‐
mine the best‐possible dosage in the therapeutic area, simultaneously decreasing its volume 
in organs and critical structures. Such adjustment can be accomplished by treatment planning 
enhancement [2–6].
This process depends on defining the location and appropriate dwell time to achieve the 
desired dose distribution in the patient’s body. Introduction of new 3D methods that are 
applied in treatment planning triggered studies on optimization algorithms using data from 
three‐dimensional imaging. One example is graphical optimization. Thanks to the informa‐
tion from target volume and surrounding it structures, optimization algorithm provided 
a possibility to target the area of interest with reference dose while protecting tissues sur‐
rounding implant. Graphical optimization allows change of shape of the isodose in any way. 
Applying such set of applicators enables the reduction of organ at risk (OARs) dose. Utilizing 
3D imaging allows us to define the exact application place as well as determine the type and 
correct amount of applicators.




In case of lung cancer, HDR brachytherapy treatment planning is conventionally based on 
two‐dimensional imaging. More and more brachytherapy departments get access to computer 
tomography, which provide three‐dimensional imaging. In our brachytherapy department, 
the entire treatment process is based on three‐dimensional imaging. Dosage distribution in 
treatment planning based on 2D imaging is conventionally set in reference points of axis. 
Reference points are identified in constant proximity from the reconstructed applicator axis, 
which usually is 1 cm. The applicators curvature is an important factor taken into consider‐
ation while calculating dose distribution in 3D‐based treatment. Dose disperse is set on the 
target area taking into consideration critical organs. Equipment routinely used for adminis‐
tering bronchial applicators in our department is a bronchovideoscope.
Before the treatment begins, the patient has computed tomography. Then, radiotherapist 
familiarizes themselves with the patient’s history and then determines the area for adminis‐
tering the ionizing radiation.
In cases where the tumor area allows for applying the catheter into the tumor, usually only 
one applicator is used. In situations where the tumor location does not allow for the direct 
application of a catheter into the tumor area, several applicators are applied into the imme‐
diate surroundings of therapeutic area. Usage of one applicator in the tumor area does not 
allow for optimal coverage by the reference dose. It is caused by unsymmetrical shape of the 
target in the reference to the applicator. By such implantation, applicator can be the reason for 
a quantity that exceeds reference dose many times over. To achieve the best coverage of the 
tumor area, it is best to use several applicators. Applicators, as long as the clinical situation 
allows, are placed to be inside the tumor and in the external target area. Such treatment allows 
the reduction of high contact dose, which is the case when using only one applicator, as well 
as a considerable dose reduction in OARs.
Once application is completed, markers are injected to each of the catheters. Markers role is 
to visualize the catheter in which stepping source is going to maneuver. The next step is to 
execute CT imaging, and it is advised to perform imaging of the entire inspiration stage. Its 
purpose is to mineralize movement of markers during the treatment. When images indicate 
patients major movements while breathing, it is necessary to repeat the procedure as there 
is a possibility of artifacts occurring, e.g., in form of blurred images. Changes in applicator 
location in reference to the target caused by the patient’s movement do not have a significant 
effect on dose dispersion in the patients system [7]. Scans are performed every 2.5 mm. In case, 
scans are performed below 2.5 mm proximity, the quality of images is significantly impaired.
Once CT images are accepted by radiotherapist and medical physicist, they are being sent to 
the computerized system of treatment planning. Radiotherapist marks each image for PTV 
and OARs areas. In lung cancer area, the critical organs are esophagus, heart, and spinal cord. 
In our department, we contour the actual image of target and critical organs on the images 
from computed tomography. Dose is specified for the entire PTV area. Most recent American 
Brachytherapy Society guidelines suggest 3D imaging for lung cancer treatment planning 
while applying HDR brachytherapy [8].
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During the next stage, medical physicist performs reconstruction of applicators trajectory. 
Selection of the optimal source step and stop place in the in the nearest proximity from PTV. 
Then, the treatment plan is being optimized. Generally, treatment plan is optimized onto 
dose reference points usually situated 1 cm from catheter axis [9]. Reference dose should be 
calculated for the target area. This process is greatly influenced by the number of applicators. 
In our department, it is usually between two and four. The number of catheters adminis‐
tered depends mainly on patient’s condition, location, and the volume of therapeutic area. 
When possible, bronchial applicators are implemented into the terminal bronchioles. Such 
allocation prevents catheter from sliding out what can stem from patient’s couch movements 
caused by the presence of excrescence in patient’s airways.
Routinely, treatment plans are optimized by graphical optimization. It is crucial to examine 
the dose dispersion in patient’s system after each modification based on graphic optimization. 
After the development process is completed, plan is evaluated. Radiotherapist analyzes vol‐
ume dose histogram (DVH). Evaluation of target coverage by reference dose in 85, 100, and 
115% volume, as well as the dose in most important critical volume structures, was done. In 
instances of heart, spinal cord, and esophagus, the dose examined was 0.1, 1, and 2 cm3 vol‐
ume in each of those structures. After initial DVH, the dose dispersion is determined on each 
cross‐section (image). After the plan is accepted, it is sent to the Treatment Control Station.
2.1.1. Case
In this case, patient is diagnosed with an inoperable non–small cell right lung cancer. Before 
the treatment begins, the patient has computed tomography (Figure 1). Overall patient’s con‐
dition and the location of changes allowed the introduction of three bronchial applicators. 
All applicators were in the immediate proximity to tumor area. Figure 2 shows scans with 
volume target contoured in computerized treatment planning systems (TPS). Illustration 
from computerized planning system depicts three‐dimensional reconstruction of bronchial 
applicators, PTV, OARs, and dose distribution (Figure 3). Reconstruction on several planes 
and DVH is presented in Figure 4. The patient was treated with 18 Gy dose in three fractions.
2.1.2. Case
Second situation presents a patient with an inoperable non–small cell right lung cancer. Before 
the treatment begins, the patient has computed tomography. Overall patient’s condition and 
the location of changes allowed the introduction of three bronchial applicators. Two applica‐
tors (nr1 and nr2) were introduced through the PTV area and planted in bronchial tubes. 
Applicator nr3 was placed where the bronchial tubes light has been blocked by the neoplastic 
changes. Very often, such applicator placement causes dilatation of bronchial tube, making 
it possible to introduce applicator through this area during next fraction. This, furthermore, 
improves the coverage on tumor area. Figure 5 shows scans with volume target contoured in 
TPS. Illustration from computerized planning system depicts three‐dimensional reconstruc‐
tion of bronchial applicators, PTV, OARs, and dose distribution (Figure 6). Reconstruction on 
several planes and DVH is presented in Figure 7. The patient was treated with 18 Gy dose in 
three fractions. In Figure 8, cancer photo was captured during the application.




In the case of skin cancer, depending on its size and location, we can differentiate several 
types of applicators. With small and superficial skin changes, usually Leipzig applicators 
are being used. When dealing with long and flat changes, i.e., on the leg, then usually 
Freiburg flap is applied. The advantage of this applicator derives from the parallel posi‐
tioning of catheters and consistent length at which they are situated. The distance of the 
catheters from the surface is also consistent. This type of applicator is also characterized 
Figure 1. CT image of the front (A) and side (B) of the patient with marked PTV.
Figure 2. Images of the TPS with PTV.
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by the high repetitiveness during the following irradiation fractions. The only requirement 
is the correct marking of applicator placement on the patient’s skin. Very often, the place 
in which cancer is situated, i.e., in nose, ear, or cheek area, doesn’t allow for application of 
standard applicators. In this case, it is very difficult to determine with the use of standard 
applicator. Using of standard applicator will not allow for ensuring optimal dose distribu‐
tion in the PTV area. It is caused by inability to adjust catheter location in reference to the 
target [10].
Applicator adjustment during the following irradiation fractions is influenced by a consid‐
erable inaccuracy margin caused by a limited applicator placement repetitiveness in regard 
to patient’s body. In cases when changes are located in close proximity to risk organs, appli‐
cator reconstruction can be planned so that it can decrease irradiation dose in those organs. 
The dose can also be reduced by appropriate arrangement of catheters in the applicator. 
Figure 3. 3D reconstruction (A, C: front; B, D: side) of PTV applicators and OARs and 3D dose reference distribution.
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In cases of shallow changes, situated in immediate proximity to applicators surface, cath‐
eters can be placed slightly further away from the target to avoid high dosage besides the 
PTV area. However, if the cancerous region is situated underneath the layer of skin and 
skin itself is OAR, the applicators will be moved toward the skin surface, inside the silicone 
Figure 4. CT images and reconstruction on several planes (A, B, and C) and DVH (D).
Figure 5. Images of the TPS with PTV.
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mask. Such applicator distribution is the reason for the high dose, and catheters being the 
source do not reach to skin region. Another way to dose distribution, and therefore pro‐
tection for critical organs, is the adoption of shields. Their task is to absorb (reduce) the 
dose, for I192 the half value is 2.5 mm for lead (HVL pb). Shields can be in the form of led 
strips in different thickness. Such shield can be produced in workshop of teleradiotherapy 
department. Shield adjustment takes place on provided patient’s gypsum cast. Shields are 
fixed in a silicone mask with the exception of the three‐dimensional computer tomography 
imaging. LED shields are the source of artifacts during CT imaging, hence disturbing the 
treatment process. Because the individual shields are removed for the CT imaging, they are 
not visible on patient’s scans sent to the computerized system of treatment planning. The 
dose that reaches critical organs protected by shields is calculated based on the thickness 
of applied shield. It is necessary to conduct in vivo dosimetry before the first irradiation to 
verify the prearranged dosage. Dosimetry can be conducted through applying the MOSFET 
detector. In cases where it is necessary to determine the dosage absorbed by an individual 
Figure 6. 3D reconstruction (A, C: front; B, D: side) of PTV applicators OARs and 3D dose reference distribution.
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Figure 8. Lung cancer photo.
Figure 7. CT images and reconstruction on several planes (A, B, and C) and DVH (D).
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shield, Micro‐MOSFET detectors are very effective, and because of their small‐scale dimen‐
sions, they can be placed between irradiative area and the shield itself. In cases where can‐
cerous changes are located in the area of nose or cheeks, it is advised to place such shields 
around patient’s eyes. Such placement prevents the shield from moving while during the 
treatment process.
Another method of manufacturing individual applicators is the usage thermoplastic mask. 
Usage of the orfit masks is widely spread in teleradiotherapy. They are applied to immobilize 
the patient during treatment with help of external bundles. They are characterized by very 
good tracing qualities. Forming process takes place on patient’s body. High level of its repro‐
ducibility is advantageous during the treatment process. They can be used to immobilize any 
location. In case of brachytherapy, such properties as reproducibility of patient’s curvatures 
are very desirable. This is one of the reasons why I became interested in applying this type of 
material in the HDR brachytherapy treatment process. The concept and theory are quite simi‐
lar to silicone masks. However, there are some relevant differences between these two types 
of individual applicators. First, it is the use of the material itself. With the orfit mask, we get 
a premade product that has to be heated. When heat treated, it becomes very malleable, and 
after applying it onto the given surface, it easily adapts to its shape. It is setting just within few 
minutes. If the reproduction is not satisfying, the material can be reheated and formed again. 
Once it reaches ambient temperature, the mask is ready to use. Another difference lays in the 
way catheters are mounted to the surface of the individual applicator. With the silicone mask, 
applicators are inside, and with the Orfit mask, they can be freely mounted onto it. So in situ‐
ation where the applicators need to be close to the surface of the skin, we can immobilize cath‐
eters by sewing them to the mask. When they have to be further away from the surface of the 
orfit mask, we can use paraffin bolus or secure silicone mask. With shields, the workflow pro‐
cedure is the same as with the silicone mask. Because we use thermoplastic material, we can 
contour the shield placement, which allows the position control throughout every treatment 
fraction. The last difference between the orfit and silicone masks is the manner of mounting 
it onto the patient. The silicone mask uses patient’s natural curvatures for the appropriate 
setting. In large areas, it is easy to adjust the applicator; however, in cases with flat areas, 
it is necessary to mark reference points on the patient’s body. Additionally, for the mask to 
adhere properly through irradiation process, it is advisable to use immobilizing bands. The 
orfit mask is fixed to the base on which the patent is laid. It is mounted to specialized brackets 
and that is why mask adjustment is the same during every fraction. Immobilizing bands are 
no more necessary nor is the marking of reference points on the patient’s body. Routinely, 
silicone masks are ready in 4 to 5 days after taking the imprint. When adopting the use of the 
orfit mask, first fraction can be performed on the same day that the patient is accepted to the 
brachytherapy department.
2.2.1. Case
The first case presents a patient with skin cancer (squamous cell carcinoma). Cancer is located 
in the vicinity of the ear. The patient was qualified for treatment with the applicator indi‐
vidual (silicone mask). In the silicone mask were placed seven applicators. The patient was 
treated with 40 Gy in 10 fractions once a day. Figure 9 shows scans with volume target con‐
toured in TPS. Illustration from computerized planning system depicts three‐dimensional 
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reconstruction applicators, PTV, and dose distribution (Figure 10). Reconstruction on several 
planes and DVH is presented in Figure 11. Patient treated with silicone mask is presented in 
Figure 12.
2.2.2. Case
The second case presents a patient with skin cancer (basal cell carcinoma). Cancer is located in 
the vicinity of the nose. The patient was qualified for treatment with the applicator individual 
(orfit mask). In the silicone mask were placed four applicators. The patient was treated with 
50 Gy in 10 fractions once a day. The patient had a shield on both eyes. Before the treatment 
begins, the patient has computed tomography to verify the mask fit to the patient (Figure 13). 
Figure 14 shows scans with volume target contoured in TPS. Illustration from TPS depicts 
three‐dimensional reconstruction applicators, PTV, OARs, and dose distribution (Figure 15). 
Reconstruction on several planes and DVH is presented in Figure 16. Patient treated with the 
orfit mask is presented in Figure 17.
2.2.3. Case
The third case presents a patient with skin cancer (basal cell carcinoma). Cancer is located in 
the vicinity of the nose. The patient was qualified for treatment with the applicator individual 
Figure 9. Images of the TPS with PTV.
Computed Tomography - Advanced Applications38
Figure 10. 3D reconstruction (A, C: front; B, D: side) of PTV applicators and 3D dose reference distribution.
Figure 11. CT images and reconstruction on several planes (A, B, and C) and DVH (D).
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Figure 12. Patient treated with the silicone mask.
Figure 13. CT image of the front (A) and side (B) of the patient with an orfit mask.
Figure 14. Images of the TPS with PTV.
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(Orfit mask). In the silicone mask were placed eight applicators. The patient was treated with 
50 Gy in 10 fractions once a day. The patient had individual shield on one eye and standard 
shield on the other eye (Figure 18). Before the treatment begins, the patient has computed 
tomography to verify the mask fit to the patient (Figure 19). Figure 20 shows scans with 
Figure 15. 3D reconstruction (A, C: front; B, D: side) of PTV applicators OARs and 3D dose reference distribution.
Treatment Planning in Brachytherapy HDR Based on Three‐Dimensional Image
http://dx.doi.org/10.5772/intechopen.68557
41
Figure 16. CT images and reconstruction on several planes (A, B, and C) and DVH (D).
Figure 17. Patient treated with an orfit mask.
Figure 18. Picture of shield.
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volume target contoured in TPS. Illustration from TPS depicts three‐dimensional reconstruc‐
tion applicators, PTV, OARs, and dose distribution (Figure 21). Reconstruction on several 
planes and DVH is presented in Figure 22. Patient treated with the orfit mask is presented 
in Figure 23
2.3. Breast cancer
With breast cancer, brachytherapy can be applied as a method associated with teleradiother‐
apy after breast‐conserving surgery. It is realized in form of boost. It can also be applied as 
an independent form of post‐surgical treatment (Accelerated Partial Breast Irradiation) as an 
alternative to the external beam radiotherapy.
Figure 19. CT image of the front (A) and side (B) of the patient with an orfit mask.
Figure 20. Images of the TPS with PTV.
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Before breast brachytherapy treatment begins, after radical dissection, it is necessary to per‐
form tumor bed imaging. Computed tomography is the advised method to apply. Before CT 
examination, it is necessary to place markers on the post‐surgical scar. The presence of this 
marker does not have a significant effect on the quality of images from CT. It is possible to use 
specialized markers for CT which, because of the material they are made of, is not the source 
of artifacts. Markers placed on the scar allow more precise tumor bed localization and there‐
fore more precise applicator administration into the tumor bed area. The process for locating 
of tumor area is facilitated by surgical clips. They are easily identifiable in CT examination. 
Their presence allows for exact defining of targets location. We can adopt two techniques with 
the boost. One technique takes advantage of a frame so‐called a template; another one on the 
other hand uses metal needles. The choice of a given technique depends mainly on target 
Figure 21. 3D reconstruction (A, C: front; B, D: side) of PTV applicators OARs and 3D dose reference distribution.
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Figure 22. CT images and reconstruction on several planes (A, B, C) and DVH (D).
Figure 23. Patient treated with an orfit mask.
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location and patient’s anatomical structure. If a patient has got big breasts and the tumor bed 
is located in the central area of the breast, then we use the template. This template consists 
of two plates and a connector which mounts those plates parallel within specified proxim‐
ity. The plates have openings through which applicators are put through. The number and 
the arrangement of the plains are the same on both plates. The distance between openings 
on plates is between 10 and 18 mm. The choice of the appropriate template depends on the 
size, positioning of the tumor bed, and patient’s anatomical structure. By using templates, the 
position of needles is parallel. By applying the template, depending on patient’s breast size, 
we can change its form. The breast is squeezed by the plates what can result in differences 
in implantation geometry. This kind of obstacle can be avoided by performing three‐dimen‐
sional imaging with already applied template. In cases where the application geometry is not 
satisfactory, it is possible to use a different template. Where the implant geometry is not sat‐
isfactory after application deriving from the used template, there is no possibility to change it 
without removing applicators.
Second technique, so‐called free hand, differs from the one already mentioned as in this case, 
the needles are applied without using templates. This technique requires extensive experi‐
ence from the person performing the treatment. Location of needles is not determined by 
the plates so they can run non parallel. Such distribution can provoke difficulties in obtain‐
ing the required spatial distribution of isodose in the target area. Creating of an acceptable 
computerized treatment plan by physicist requires wide experience in this type of applica‐
tion. It is simply because it is possible that some areas can occur with higher or lower dosage 
than the reference dosage prepared for PTV areas. This method can be successfully applied 
with small and average breasts. Arbitrariness in needle maneuvering in the breast allows for 
higher degree of risk organs protection. After applying templates, skin, as its being squeezed 
by plates, can move to closer proximity to the PTV area. This can cause telangiectasias in the 
skin area. When applicators are applied free hand, tumor beds do not change their location 
in reference to the skin. In cases where tumor bed is positioned in small proximity to the 
chest wall, it is possible to introduce applicators directly into bed area while applying the 
free‐hand technique. Where templates are used, structure of the plate reduces the possibility 
of introducing applicators in the PTV area. After deciding on palliation technique based on 
previously performed imaging, we can proceed to needle implantation. During application, it 
is possible to perform low‐dose CT in order to regulate applicator’s trajectory through tumor 
bed area. After application is completed, it is necessary to secure the needles from moving 
out by applying clips onto them. It is particularly important when taking advantage of this 
technique, but it also secures the needles from relocation while attaching transfer tubes. It is 
crucial to remove mandrins from the needles as they are the source of numerous artifacts in 
computer tomography imaging. They significantly affect the image quality especially because 
they are in the PTV area.
In case of brachytherapy as an independent form of treatment, we can use several differ‐
ent applicators. As with the boost, we can apply plate/template techniques. The difference 
between boost procedures and unassisted treatment lies mainly in the number of fractions. 
Boost is applied in one of the fractions whereas Accelerated Partial Breast Irradiation (APBI) 
in eight fractions. Because of that, all metal needles have been replaced with plastic guides, 
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which remain in patient’s body through the whole treatment process. The guides are closed 
up with clips on the one end, whereas on the other end, we can find a connector that mounts 
introduced needle. Plastic needle is present in patient’s body only during irradiation; they 
are being removed once irradiation has been completed. Because those needles are made of 
plastic, it is necessary to introduce dedicated markers to make them visible in CT imaging. 
Another method applied is so‐called balloon method which takes advantage of SAVI appli‐
cator. This applicator consists of several channels with in its central part and rest in its cir‐
cumferential area. To be able to apply this applicator, the patient has to be operated for open 
cavity surgery. After introducing applicator into tumor bed, it is being adjusted by dilating 
channels located on its boarders (circumferentially). Applicator is monitored by ultrasonogra‐
phy (USG) while being introduced; then, thee‐dimensional imaging is performed. Before CT 
examination, it is important to mark one of the channels on patient’s body to be able to verify 
applicator’s location in reference to the tumor bed. Verification should be taken place before 
each and every irradiation fraction. The applicator is introduced into patient’s body for the 
whole time of treatment process. Breast cancer treatment process based on three‐dimensional 
images allows you to determine the dosage for the actual PTV area. Taking advantage of com‐
puter tomography made it possible to search for new types of applicators, which, in course, 
allows to cover the desirable target area and protection of critical organs. TPS images present 
marked the target and all risk organs. Reference dose is specified for the whole PTV area, and 
risk organs in this case are skin area and the wall of the chest. In case of boost, the dosage 
equals 10 Gy, and in case of APBI/SAVI, it is 4 Gy 8 times twice a day [11].
2.3.1. Case
The first case presents a patient with breast cancer. The patient is after conservative treatment. 
Treatment is realized in the form of boost after external beam radiotherapy. The patient was 
treated with 10 Gy in 1 fraction. Before the treatment begins, the patient has computed tomog‐
raphy (Figure 24).The patient was treated with template. In the tumor bed were placed five 
applicators. Figure 25 shows scans with volume target contoured in TPS. Illustration from 
computerized planning system depicts three‐dimensional reconstruction applicators, PTV, 
and dose distribution (Figure 26). Reconstruction on several planes and DVH is presented 
in Figure 27.
2.3.2. Case
The second case presents a patient with breast cancer. Patient is after breast‐conserving sur‐
gery. Treatment is realized in the form of boost after external beam radiotherapy. The patient 
was treated with 10 Gy in 1 fraction. Before the treatment begins, the patient has computed 
tomography (Figure 28). The patient was treated with the free‐hand technique. In the tumor 
bed were placed eight applicators. Figure 29 shows scans with volume target contoured in 
TPS. Illustration from computerized planning system depicts three‐dimensional reconstruc‐
tion applicators, PTV, and dose distribution (Figure 30). Reconstruction on several planes 
and DVH is presented in Figure 31. Patient with breast cancer treated using the free‐hand 
technique is presented in Figure 32.




The third case presents a patient with breast cancer. Patient is after breast‐conserving sur‐
gery. Treatment is realized in the form of post‐surgical treatment (Accelerated Partial Breast 
Irradiation). The patient was treated with 32 Gy in eight fractions twice a day. Before the treat‐
ment begins, the patient has computed tomography (Figure 33). In the tumor bed were placed 
12 applicators. Figure 34 shows scans with volume target contoured in TPS. Illustration from 
computerized planning system depicts three‐dimensional reconstruction applicators, PTV, 
and dose distribution (Figure 35). Reconstruction on several planes and DVH is presented 
in Figure 36.
Figure 24. CT image before application with a marked scar.
Figure 25. Images of the TPS with PTV.
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2.3.4. Case
The fourth case presents a patient with breast cancer. Patient is after breast‐conserving sur‐
gery. Treatment is realized in the form of post‐surgical treatment (Accelerated Partial Breast 
Irradiation). The patient was treated with 34 Gy in 10 fractions twice a day. Patient was treated 
by using applicator SAVI. Before the treatment begins, the patient has computed tomography 
Figure 26. 3D reconstruction (A, C: front; B, D: side) of PTV applicators OARs and 3D dose reference distribution.
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(Figure 37). In the tumor bed was placed one applicator with seven channels. Figure 38 shows 
scans with volume target contoured in TPS. Illustration from computerized planning system 
depicts three‐dimensional reconstruction applicators, PTV, and dose distribution (Figure 39). 
Reconstruction on several planes and DVH is presented in Figure 40.
Figure 27. CT images and reconstruction on several planes (A, B, and C) and DVH (D).
Figure 28. CT images before application with a marked scar.
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Figure 29. Images of the TPS with PTV.
Figure 30. 3D reconstruction (A, C: front; B, D: side) of PTV applicators OARs and 3D dose reference distribution.
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Figure 31. CT images and reconstruction on several planes (A, B, and C) and DVH (D).
Figure 32. Patient with breast cancer treated using the free‐hand technique.
Figure 33. CT images before application with a marked scar.
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Figure 34. Images of the TPS with PTV.
Figure 35. 3D reconstruction (A, C: front; B, D: side) of PTV applicators OARs and 3D dose reference distribution.




Standard hospitalization procedure for patients suffering from prostate cancer in HDR 
brachytherapy is ultrasonographic imaging. Applicators used for the treatment are metal and 
plastic needles. Images are generated by Transrectal Ultrasound Scan (TRUS). Normally, the 
treatment kit consists of a transrectal probe that is mounted onto so‐called stepper. A stepper 
is a set of mechanical lever system, a specialized stand with longitudinal boat for USG head at 
Figure 36. CT images and reconstruction on several planes (A, B, and C) and DVH (D).
Figure 37. CT images before application with a marked scar.
Computed Tomography - Advanced Applications54
Figure 38. Images of the TPS with PTV.
Figure 39. 3D reconstruction (A, C: front; B, D: side) of PTV applicators OARs and 3D dose reference distribution.
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its peak. During treatment, stepper was immobilized by being fixed to the floor. This prevents 
potential twists as well as target volume reading errors through planning system. Important 
function of the stepper was support of special ceramic targeting plate (template) and ultra‐
sonographic head. This plate has a grid of coordinate system correlating to this equivalently 
in the planning system. It is setting distance between the needles and the correct direction of 
the needle applicators is established. Gland images acquired from the ultrasonograph (1 mm 
intervals) were sent to the planning system simultaneously (on‐line), enabling real‐life change 
in volume target irradiation in reference to metal applicators and neighboring organs.
Prostate cancer can also be treated with means of HDR brachytherapy based on three‐dimen‐
sional imaging from computer tomography. In this case, the procedure is more complicated 
compared to applying TRUS. This technique is usually applied with patients who already 
went through surgery where rectum was removed along the cancerous tumor. It is not pos‐
sible to introduce transrectal probe after having undergone Miles surgery. Treatment is con‐
ducted with the help of computer tomography. We do not have an online preview while 
inserting catheters into the prostate area. The patient is laid in lateral position and not, as it 
is for standard treatment, in gynecological position. The reason for this comes from the fact 
that the treatment itself takes place on computer tomography. With patient laid like that, we 
can introduce applicators and perform CT imaging. They do not have to change the posi‐
tion between application and imaging processes. Hence, the danger of applicator relocation 
caused by patient’s movement is eliminated. Furthermore, the position and inability to apply 
the stepper exclude the option of applying the ceramic plate. The needles are reviewed in the 
free‐hand technique. Before the treatment begins, a three‐dimensional imaging is performed 
to determine target’s location as well as its volume. After the analysis of 3D images, the depth 
to which applicators will be introduced into patient’s body can be determined. After first few 
Figure 40. CT images and reconstruction on several planes (A, B, and C) and DVH (D).
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needles have been applied, another computer tomography is performed to examine applica‐
tion geometry. The location as well as the depth, to which applicators have been introduced, 
is being inspected. Verification scheme is repeated after applying few applicators. After the 
application process is completed, a CT imaging is performed. Then, the images are sent to TPS 
with marked PTV and OAR areas. Prostate treatment planning based on CT imaging requires 
great experience from radiotherapist while introducing the needles into the prostate area. 
Medical physicists have to possess a wide experience in this type of procedures. In cases where 
needles are injected “free hand,” it is common for catheters to intersect in patient’s body, what 
in consequence can lead to difficulties when identifying individual applicators [12].
2.4.1. Case
The first case presents a patient with prostate cancer. Miles operation is a surgery for rectal 
cancer or anal cancer. The patient was treated with 30 Gy in two fractions twice a day. During 
application, the patient had twice CT examination for verification (Figure 41). In the tumor 
bed were placed 12 applicators. Figure 42 shows scans with volume target contoured in TPS. 
Illustration from computerized planning system depicts three‐dimensional reconstruction 
applicators, PTV, and dose distribution (Figure 43). Reconstruction on several planes and 
DVH is presented in Figure 44.
Figure 41. CT images: first imaging (A, B) and second imaging (C, D).
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Figure 42. Images of the TPS with PTV.
Figure 43. 3D reconstruction (A, C: front; B, D: side) of PTV applicators and 3D dose reference distribution.
Computed Tomography - Advanced Applications58
3. Summary
Treatment planning in HDR brachytherapy based on three‐dimensional imaging allows for 
prearranging and conducting optimal treatment in a given location. Routinely, in parts like 
the lung or esophagus, treatment plan is based on 2D imaging. Academic literature provides 
reports about incorporating 3D along with 2D imaging in lung cancer treatment. Significant 
differences are also pointed out when it comes to the coverage of the therapeutic area between 
these two methods. Thanks to the use of computer tomography, we have got the precise loca‐
tion of the irradiation area. We can adjust the most appropriate technique and applicators to 
conduct the most optimal treatment. What’s more, the geometry of introduced implant allows 
for the ultimate target coverage with simultaneous protection of organs at risk
Utilizing three‐dimensional imaging provides great possibility for treatment in location 
where previous access was hindered or impossible because of patient’s anatomical structure 
or previously undergone procedures, i.e., Miles surgery.
Computer tomography allows for establishing individual treatment solutions that provide 
optimal approach to every patient as in skin cancer. With more and easier access to three‐
dimensional imaging, new ways of applying HDR brachytherapy open in new location as 
well as in form of radical treatment. With the use of imaging, we are now able to introduce 
catheters precisely into the tumor area with putting the patient at risk of posttreatment com‐
plications. It allows the treatment of people that no more qualify for other forms of treatment 
(radiotherapy). Because of the high gradient dose in HDR brachytherapy and patients with 
internal intracranial implants, i.e., pacemaker or cardioverter‐defibrillator, we know exactly 
Figure 44. CT images and reconstruction on several planes (A, B, and C) and DVH (D).
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the dose the device will receive, so we can perform the procedures without exposing the 
patient to additional risk. Thanks to different optimization forms based on 3D images, HDR 
brachytherapy is applied not only in palliative treatment but also in new ways of radical treat‐
ment, i.e., in case of APBI.
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